PCSK9 inhibitors in the prevention of cardiovascular disease - Wikidata - awgldk - TriplyDB

PCSK9 inhibitors in the prevention of cardiovascular disease

PCSK9 inhibitors in the prevention of cardiovascular disease

http://www.wikidata.org/entity/Q28071452

about

Genetics of Dyslipidemia and Ischemic Heart Disease.Genes for a 'Wellderly' Life.PCSK9 as a therapeutic target for cardiovascular disease.Quantitative characterization of the mechanism of action and impact of a 'proteolysis-permitting' anti-PCSK9 antibody.Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor Therapy: Payer Approvals and Rejections, and Patient Characteristics for Successful Prescribing.Implementing genome-driven personalized cardiology in clinical practice.Association of alirocumab therapy with inflammatory lesions of the vocal folds: A case report.

P2860

Q38692446-A471D2BB-86B6-48A2-B5DC-63B68EDC3D28 Q40951106-47A0B259-970E-413C-83C2-BC54BED6D089 Q41822823-97F79CB1-3A9E-4A68-B865-A32C88645922 Q42323238-CA688911-BE70-4F7D-BCAB-2CB17CFCC940 Q47587162-BA2E16CE-E3A4-4299-B91A-F2BBC7AF83A3 Q49990965-A3C54F1B-FAF5-4021-B541-3DF80F56C1A4 Q51277639-8F05801C-FCB7-40C9-8CD8-5F9689DD1714

P2860

PCSK9 inhibitors in the prevention of cardiovascular disease

http://www.wikidata.org/entity/Q28071452

description

2016 nî lūn-bûn

@nan

2016 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

PCSK9 inhibitors in the prevention of cardiovascular disease

@ast

PCSK9 inhibitors in the prevention of cardiovascular disease

@en

PCSK9 inhibitors in the prevention of cardiovascular disease

@nl

type

label

PCSK9 inhibitors in the prevention of cardiovascular disease

@ast

PCSK9 inhibitors in the prevention of cardiovascular disease

@en

PCSK9 inhibitors in the prevention of cardiovascular disease

@nl

prefLabel

PCSK9 inhibitors in the prevention of cardiovascular disease

@ast

PCSK9 inhibitors in the prevention of cardiovascular disease

@en

PCSK9 inhibitors in the prevention of cardiovascular disease

@nl

P1433

Q28071452-958AF087-DAB3-46E3-8B0E-3CBF3A63DFE3

P1476

Q28071452-77F44396-CCC6-4890-829A-F2A6795AB765

P2093

Q28071452-3A5EC347-8605-4CE3-A5FA-3A6F2AC5BF89

Q28071452-5AC25D27-F0B7-4460-8E57-91FEF62531F8

Q28071452-A21943CC-C344-4096-BBBD-B0CD0FE25EC0

Q28071452-FC835D4B-86A9-4705-B4B1-0783D47001C9

P275

Q28071452-119A0D5E-5315-479D-A44E-A59870C84223

P2860

Q28071452-073A98F0-D664-4326-8CE4-084962ECA4F3

Q28071452-0D6A13D3-0B43-4248-815C-DAAF9E723455

Q28071452-115E5917-F670-404E-B1D7-5B389FEED026

Q28071452-1185AB7E-B971-4F3D-9764-6AC4C772EFC1

Q28071452-17504B18-F9A4-47A2-9B68-F0B67C256ABC

Q28071452-1D1CF877-CD83-4F11-AE2C-1569A47637C3

Q28071452-203F411F-61B8-4171-BB37-9C833BE580A9

Q28071452-26C44A06-DCB3-47AA-A7F3-6C2B8434A079

Q28071452-26F605DE-D933-44C9-B7C7-54F6228BB838

Q28071452-2843984F-C227-48E8-AD6E-322382975029

P2888

Q28071452-72ACE4FA-F4E4-4FD5-9B33-F6F4E6E23CA3

P304

Q28071452-EB239222-A40D-49B0-B676-A82E8EEB5ECB

P31

Q28071452-037A9CFA-D93D-4458-AFCE-091F70A1C2B0

Q28071452-12902539-2967-4754-8E15-06E33E695000

P3181

Q28071452-7436D207-6036-4754-A79C-56A29DDB8B4A

P356

Q28071452-9CBB1C9E-561F-4E21-B97A-B8C271C7F650

P407

Q28071452-27F56CBA-AA6E-413B-91A1-182BCF55E3B8

P433

Q28071452-BCF83229-1848-46C9-96FA-A0E0A0E84207

P478

Q28071452-D58B8440-939D-4BC9-B78C-A834758CFB29

P577

Q28071452-8BEB42EB-1B6E-4D4C-92BD-3B6B2F06B4E5

Q28071452-FAEDCBDD-1A8A-40B3-BAF1-9E29C18DF40D

P5875

Q28071452-B2D68F69-1E7E-4324-A052-7F2D33A5DD94

P698

Q28071452-7C6F240D-5E33-4A44-A74F-444F52A9F0F7

P921

Q28071452-B319ADC2-0D6C-4BC4-905D-388630E170A1

Q28071452-C82AF0AC-24BA-4699-8517-E039539949C6

P932

Q28071452-C29CA72F-AF24-4251-B6DA-0082E830357B

P3181

P356

S11239-016-1364-1

P1433

Journal of Thrombosis and Thrombolysis

P1476

PCSK9 inhibitors in the prevention of cardiovascular disease

@en

P2093

James Latimer

http://www.w3.org/2001/XMLSchema#string

Jonathan A. Batty

http://www.w3.org/2001/XMLSchema#string

R. Dermot G. Neely

http://www.w3.org/2001/XMLSchema#string

Vijay Kunadian

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

The secretory proprotein convertase neural apoptosis-regulated convertase 1 (NARC-1): liver regeneration and neuronal differentiation

Hepatic PCSK9 expression is regulated by nutritional status via insulin and sterol regulatory element-binding protein 1c

The cellular trafficking of the secretory proprotein convertase PCSK9 and its dependence on the LDLR

Self-association of human PCSK9 correlates with its LDLR-degrading activity

Adenoviral-mediated expression of Pcsk9 in mice results in a low-density lipoprotein receptor knockout phenotype

The PCSK9 decade

PCSK9 LNA antisense oligonucleotides induce sustained reduction of LDL cholesterol in nonhuman primates

Therapeutic RNAi targeting PCSK9 acutely lowers plasma cholesterol in rodents and LDL cholesterol in nonhuman primates

The LDL receptor

Phenotype standardization for statin-induced myotoxicity

P2888

s11239-016-1364-1

P304

405-19

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2224380

http://www.w3.org/2001/XMLSchema#string

P356

10.1007/S11239-016-1364-1

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

42

http://www.w3.org/2001/XMLSchema#string

P577

2016-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

301537327

http://www.w3.org/2001/XMLSchema#string

P698

27095708

http://www.w3.org/2001/XMLSchema#string

P921

cardiovascular disease

P932

5010583

http://www.w3.org/2001/XMLSchema#string